Operetta CLS High-Content Analysis System
6 February 2018 | By PerkinElmer
Operetta CLS is a high-content cell analysis system featuring a unique combination of technologies to deliver high speed, sensitivity, and resolution...
List view / Grid view
6 February 2018 | By PerkinElmer
Operetta CLS is a high-content cell analysis system featuring a unique combination of technologies to deliver high speed, sensitivity, and resolution...
Signs collaboration agreement with AstraZeneca to offer state-of-the-art technology to clients.
1 February 2018 | By PerkinElmer
This webinar discussed a screening assay that recapitulates the activation of ER stress sensor IRE1 and an assay to quantify cell migration phenotypes, as applied to cardiovascular target validation and drug discovery.
Targeted interventions can significantly improve screening for diabetic retinopathy, according to a new Cochrane Systematic Review.
Due to their role in signal transmission from the outside to the inside of a cell, G-protein coupled receptors are prominent drug targets...
26 January 2018 | By PerkinElmer
The JANUS G3 automated workstation offers multiple pipetting technologies on a single instrument platform.
Reasons for phenotypic vs. target based drug discovery strategies, challenges of and maximising return of phenotypic assays.
Scientists discover that altered gut microbiome populations appear to influence the onset of blood infections in paediatric cancer patients.
Describing how a single nuclear stain can enable phenotypic profiling for new and additional perspectives on assays at no extra cost.
Water immersion lenses provide: brighter images from HCS samples; faster and gentler imaging; higher quality images from both 2D and 3D samples.
Researchers have developed a single blood test that screens for eight common cancer types and helps identify the location of cancer...
Researchers have demonstrated how a pixelated gene expression tool can accurately measure RNA levels more quickly than existing methods allow.
Researchers have outlined a pioneering method of screening a person’s diverse set of antibodies for rapid therapeutic discovery.
This year, BMG LABTECH’s Australian office celebrates 20 years of innovation and steady growth. The office was established in January 1998 to support Australia and the APAC region, offering excellent sales and customer service for BMG LABTECH’s wide range of dedicated and multi-mode microplate readers.
15 January 2018 | By BMG Labtech GmbH
Optimising the receptor binding kinetics of new drugs can have significant benefits, ranging from improved duration of action to enhanced efficacy through the insurmountable antagonism of dynamic physiological systems.Despite this, the kinetics of new receptor ligands are rarely measured early in the drug discovery process, largely because current assays are…